Q3 in line
Euromoney Institutional Investor | 19/07/2019

Euromoney’s Q3 trading update indicated overall trading performance in line with management expectations and we have not changed our FY19 estimates.…

Paediatric AKI application pulled, Q4 resubmission
BioPorto Diagnostics | 19/07/2019

In July 2019 BioPorto announced that the FDA had requested additional information for The NGAL Test’s 510(k) application for paediatric acute kidney…

Executive Interview
Silence Therapeutics | 18/07/2019

In this interview with David Horn Solomon, CEO of Silence Therapeutics, he discusses today’s announcement of a licensing and collaboration agreement…

Another record quarter
Esker | 18/07/2019

Continued strong demand for Esker’s SaaS-based software in H119, with group revenue growth of 17% y-o-y and the value of contracts signed 51% higher…